Ryan Specialty Holdings Inc. (RYAN)
(Real Time Quote from BATS)
$42.03 USD
+0.03 (0.07%)
Updated Jan 31, 2023 12:11 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for Ryan Specialty Holdings Inc falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | |
---|---|---|---|---|---|
Sales | NA | 1,433 | 1,018 | 765 | NA |
Cost Of Goods | NA | 0 | 0 | 0 | NA |
Gross Profit | NA | 1,433 | 1,018 | 765 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 1,246 | 860 | 664 | 0 |
Income After Depreciation & Amortization | 0 | 187 | 159 | 101 | 0 |
Non-Operating Income | NA | -46 | -32 | 2 | NA |
Interest Expense | NA | 79 | 47 | 36 | NA |
Pretax Income | NA | 62 | 79 | 68 | NA |
Income Taxes | NA | 5 | 9 | 5 | NA |
Minority Interest | NA | -9 | 2 | -1 | NA |
Investment Gains/Losses | NA | 0 | 0 | 0 | NA |
Other Income/Charges | NA | 0 | 0 | 0 | NA |
Income From Cont. Operations | NA | 57 | 71 | 63 | NA |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | NA |
Net Income (GAAP) | NA | 66 | 68 | 64 | NA |
Depreciation Footnote | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | 311 | 231 | 156 | 0 |
Depreciation & Amortization (Cash Flow) | NA | 124 | 73 | 55 | NA |
Income After Depreciation & Amortization | 0 | 187 | 159 | 101 | 0 |
Earnings Per Share Data | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Average Shares | NA | 105.73 | NA | NA | NA |
Diluted EPS Before Non-Recurring Items | NA | 1.08 | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | -0.07 | NA | NA | NA |
Fiscal Year end for Ryan Specialty Holdings Inc falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 | 12/31/21 | |
---|---|---|---|---|---|
Sales | NA | 412.00 | 491.29 | 386.89 | 378.54 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 412.00 | 491.29 | 386.89 | 378.54 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 350.65 | 385.76 | 343.50 | 323.29 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 61.35 | 105.53 | 43.39 | 55.25 |
Non-Operating Income | NA | 0.21 | 0.61 | -8.06 | -0.77 |
Interest Expense | NA | 28.86 | 24.85 | 21.75 | 19.13 |
Pretax Income | NA | 32.69 | 81.29 | 13.57 | 35.35 |
Income Taxes | NA | 3.41 | 11.17 | -4.50 | 5.73 |
Minority Interest | NA | 17.53 | 45.62 | 11.17 | 19.57 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 29.28 | 70.12 | 18.08 | 29.62 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 11.75 | 24.50 | 6.91 | 10.05 |
Earnings Per Share Data | 12/31/22 | 9/30/22 | 6/30/22 | 3/31/22 | 12/31/21 |
---|---|---|---|---|---|
Average Shares | NA | 266.35 | 304.87 | 264.12 | 296.16 |
Diluted EPS Before Non-Recurring Items | NA | 0.25 | 0.39 | 0.24 | 0.29 |
Diluted Net EPS (GAAP) | NA | 0.09 | 0.22 | 0.06 | 0.09 |